Rise and shine, everyone. Another day is on the way. And here on the Pharmalot corporate campus we have been hustling to deposit the short people at their various schoolhouses. Yes, this calls for at least two cups of mandatory stimulation - and the day has only just begun. Nonetheless, we will push on. We trust you will do the same. To help you along, here are some items of interest. Hope your day goes well and you accomplish much...
Pfizer Starts Viagra Patent Case Against Teva In Russia (Reuters)
J&J Sees Shortage Of Cancer Drug Persisting (Dow Jones)
Express Scripts Hires Former Committee Staffer To Lobby On Merger (The Hill)
Qatar Puts A Cap On Wholesaler Price Hikes (The Peninsula)
AstraZeneca Plans Bioinformatics Center In Russia (BioIT World)
Novartis Seeks Approval For Smoker's Cough Drug (Reuters)
Lilly Gets Positive European Opinion On Alimta (Indiananapolis Business Journal)
HRT Meds Need A Stronger Asthma Warning (Pharma Times)
Childhood Vaccine Funds Agreed For More Poor Nations (Reuters)
Healthcare Businesses Want US Free-Trade Policy Built Around Industry (Sun-Herald)
Intercell Is In Talks With Private Equity (Bloomberg News)
EDITOR'S NOTE: Please check this post for updates throughout the morning